Cargando…

Mucopolysaccharidosis (MPS): Review of the literature and case series of five pediatric dental patients

Patients with MPS present with a plethora of dental manifestations, accompanying behavioral difficulties and medical comorbidities which often dictate the need for treatment in specialist centers. Prevention is therefore mandatory in this high‐risk group.

Detalles Bibliográficos
Autores principales:	Hirst, Lorna, Mubeen, Suhaym, Abou‐Ameira, Gehan, Chakrapani, Anupam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981707/ https://www.ncbi.nlm.nih.gov/pubmed/33768919 http://dx.doi.org/10.1002/ccr3.3885

Ejemplares similares

Impact of dietary interventions in inborn errors of metabolism in paediatric dentistry: Review of the literature and case series
por: Hirst, Lorna, et al.
Publicado: (2020)

Hypophosphataemic Rickets Secondary to Raine Syndrome: A Review of the Literature and Case Reports of Three Paediatric Patients' Dental Management
por: Hirst, Lorna, et al.
Publicado: (2021)

Multiple Sulfatase Deficiency (MSD): Review of the Literature and Case Reports of Two Siblings with Dental Caries and Trauma
por: Hirst, Lorna, et al.
Publicado: (2021)

Immunological evaluation of patients with mucopolysaccharidosis (MPS)
por: Aranda, Carolina, et al.
Publicado: (2015)

Genotype‐phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry
por: Clarke, Lorne A., et al.
Publicado: (2019)

Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry
por: D’Aco, Kristin, et al.
Publicado: (2012)

Parents’ experiences of living with, and caring for children, adolescents and young adults with Mucopolysaccharidosis (MPS)
por: Somanadhan, S., et al.
Publicado: (2016)

Sexual behaviour in a murine model of mucopolysaccharidosis type I (MPS I)
por: Barbosa Mendes, Ana, et al.
Publicado: (2019)

Mucopolysaccharidosis type VI (MPS VI) and molecular analysis: Review and classification of published variants in the ARSB gene
por: Tomanin, Rosella, et al.
Publicado: (2018)

Novel approach to idursulfase and laronidase desensitization in type 2 and type 1 S mucopolysaccharidosis (MPS)
por: Spataro, Federico, et al.
Publicado: (2022)

Report of Five Years of Experience in Neonatal Screening for Mucopolysaccharidosis Type I and Review of the Literature
por: Gragnaniello, Vincenza, et al.
Publicado: (2020)

PReS-FINAL-2244: Ultrasound examination reveals typical alterations in joints of mucopolysaccharidosis (MPS) patients
por: Karabul, N, et al.
Publicado: (2013)

Mucopolysaccharidosis: Cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI
por: Brands, Marion M. M. G., et al.
Publicado: (2012)

Enzyme replacement therapy for Mucopolysaccharidosis Type I among patients followed within the MPS Brazil Network
por: Dornelles, Alícia Dorneles, et al.
Publicado: (2014)

Clinical Characteristics and Healthcare Resource Utilization for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review
por: Ayodele, Olulade, et al.
Publicado: (2022)

Proposal of an Algorithm to Early Detect Attenuated Type I Mucopolysaccharidosis (MPS Ia) among Children with Growth Abnormalities
por: Baronio, Federico, et al.
Publicado: (2022)

Airway management in mucopolysaccharidosis: a retrospective case series review
por: Tümer, Murat, et al.
Publicado: (2021)

Pregnancy in patients with mucopolysaccharidosis: a case series
por: Stewart, Fiona J., et al.
Publicado: (2016)

Atypical microbial infections of digestive tract may contribute to diarrhea in mucopolysaccharidosis patients: a MPS I case study
por: Węgrzyn, Grzegorz, et al.
Publicado: (2005)

Growth in individuals with attenuated mucopolysaccharidosis type I during untreated and treated periods: Data from the MPS I registry
por: Polgreen, Lynda E., et al.
Publicado: (2022)

Molecular Characterization of a Novel Splicing Mutation Underlying Mucopolysaccharidosis (MPS) Type VI—Indirect Proof of Principle on Its Pathogenicity
por: Coutinho, Maria Francisca, et al.
Publicado: (2020)

Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder?
por: Horgan, Claire, et al.
Publicado: (2022)

Mucopolysaccharidosis Type II: A Kenyan Case Series
por: Mungai, L. N. Wainaina, et al.
Publicado: (2021)

The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II)
por: Sampayo-Cordero, Miguel, et al.
Publicado: (2020)

Elevated fracture of skull in pediatric age group: A series of five patients with review of literature
por: Kumar, Jayendra, et al.
Publicado: (2016)

Mucopolysaccharidosis: What Pediatric Rheumatologists and Orthopedics Need to Know
por: Costi, Stefania, et al.
Publicado: (2022)

Gastrointestinal Manifestations in Mucopolysaccharidosis Type III: Review of Death Certificates and the Literature
por: Thomas, Sophie, et al.
Publicado: (2021)

Mucopolysaccharidosis: A broad review
por: Nagpal, Ritu, et al.
Publicado: (2022)

Understanding disease symptoms and impacts and producing qualitatively-derived severity stages for MPS IIIA: a mixed methods approach
por: Lanar, Sally, et al.
Publicado: (2022)

Impact of the Timing of Enzyme Replacement Therapy Initiation and Cognitive Impairment Status on Outcomes for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review
por: Yee, Karen S., et al.
Publicado: (2022)

Hyperammonaemia in classic organic acidaemias: a review of the literature and two case histories
por: Häberle, Johannes, et al.
Publicado: (2018)

Clinical and Molecular Characterization of Patients with Mucopolysaccharidosis Type I in an Algerian Series
por: Tebani, Abdellah, et al.
Publicado: (2016)

Mucopolysaccharidosis VI
por: Valayannopoulos, Vassili, et al.
Publicado: (2010)

Dysostosis in mucopolysaccharidosis type 2: A case of longitudinal follow up and literature review
por: Sasaki, Tomoaki, et al.
Publicado: (2021)

Airway Abnormalities in Adult Mucopolysaccharidosis and Development of Salford Mucopolysaccharidosis Airway Score
por: Gadepalli, Chaitanya, et al.
Publicado: (2021)

Differences in MPS I and MPS II Disease Manifestations
por: Hampe, Christiane S., et al.
Publicado: (2021)

Diagnosing mucopolysaccharidosis IVA
por: Wood, Timothy C., et al.
Publicado: (2013)

Mucopolysaccharidosis-Plus Syndrome
por: Vasilev, Filipp, et al.
Publicado: (2020)

Mucopolysaccharidosis Type I
por: Kubaski, Francyne, et al.
Publicado: (2020)

Hearing Loss in Mucopolysaccharidosis
por: Bicalho, Cibele Gomes, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bdqa4adeai8h3p33t67rfeiho8